1.15 USD
▼+0.03-7.26%
盘后 1.25 +0.42%
2026-08-03
市值
$79.09M
市盈率
—
EPS
-0.28
股息率
—
52 周区间
0.89 – 2.09
成交量
81.65K
Beta
-0.24
目标价
—
52W 低 0.8952W 高 2.09
价格走势
公司简介
Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases. It is developing Telomir-1, an oral small molecule metal ion regulator designed to protect against age-related conditions, including Wilson’s disease, Type 2 diabetes, age-related macular degeneration (AMD), oncology, and epigenetic regulation, as well as Alzheimer’s disease and Progeria. The company was formerly known as Metallo The...